Calamos Wealth Management LLC Sells 24,057 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Calamos Wealth Management cut its Intuitive Surgical stake by 96.3% in the third quarter, selling 24,057 shares and retaining 918 shares valued at about $373,000.
• Intuitive Surgical’s latest reported quarter beat expectations: EPS was $3.00 versus a $2.65 consensus, revenue reached $3.05 billion, and revenue grew 21.7% year over year.
• Analysts’ consensus rating was “Moderate Buy”, with an average price target of $493.54; company insiders also reported selling shares, including director Gary Guthart under a pre-arranged trading plan.

Calamos Wealth Management LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 96.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 918 shares of the medical equipment provider's stock after selling 24,057 shares during the quarter. Calamos Wealth Management LLC's holdings in Intuitive Surgical were worth $373,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Main Street Group LTD acquired a new stake in Intuitive Surgical in the first quarter valued at approximately $30,000. North Point Portfolio Managers Corp OH purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $27,000. John Boyer Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $27,000. Compass Wealth Management LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $29,000. Finally, Evergreen Advisors LLC purchased a new position in shares of Intuitive Surgical during the 1st quarter valued at approximately $35,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In related news, Director Gary Guthart sold 20,095 shares of the business's stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the transaction, the director directly owned 1,204,530 shares in the company, valued at approximately $543,977,793.30. The trade was a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the company's stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president directly owned 881 shares of the company's stock, valued at approximately $330,877.17. This represents a 8.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 49,128 shares of company stock valued at $21,614,167 in the last ninety days. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on ISRG shares. Oppenheimer reissued an "outperform" rating and issued a $500.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Wednesday, October 21st. Barclays reaffirmed an "overweight" rating and set a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. Mizuho dropped their target price on shares of Intuitive Surgical from $415.00 to $400.00 and set a "neutral" rating on the stock in a research report on Wednesday, October 21st. Finally, Robert W. Baird boosted their target price on shares of Intuitive Surgical from $513.00 to $550.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $493.54.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $452.80 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock's fifty day moving average is $409.93 and its two-hundred day moving average is $431.89. The firm has a market capitalization of $156.96 billion, a P/E ratio of 54.75, a PEG ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company's revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.40 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

About Intuitive Surgical

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.